Ligands for opioid and σ-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress

Life Sciences

Volumn 65, Issue 1, 1999, Pages

  Lishmanov, Yu B ^a   Maslov, L N ^a   Naryzhnaya, N V ^a   Tam, S W ^b  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b NitroMed Inc   (United States)

Author keywords

Cardiac arrhythmias; Cardiosclerosis; Opioid receptors; Rat; Sigma receptor; Stress

Indexed keywords

1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE; BETA ENDORPHIN; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LIGAND; MORPHINE; NALOXONE; OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; SPIRADOLINE; TYROSYL DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SIMULATION; DOSE RESPONSE; HEART INFARCTION; HEART MUSCLE EXCITABILITY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BETA-ENDORPHIN; DISEASE MODELS, ANIMAL; DYNORPHINS; ENKEPHALIN, LEUCINE-2-ALANINE; HEART; IMMOBILIZATION; LIGANDS; MORPHINE; MYOCARDIAL INFARCTION; MYOCARDIUM; NALOXONE; NALTREXONE; OLIGOPEPTIDES; PIPERIDINES; PYRROLIDINES; RATS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; STRESS; VENTRICULAR FIBRILLATION;

ANIMALIA;

EID: 0010972560     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00226-X     Document Type: Article

References (20)

1. W.B. Kannel, J.F. Plehn and L.A. Cupples, Am. Heart J. 115 869-875 (1988).
2. C. Oakley, Am. J. Cardiol. 67 26C-28C (1991).
3. D.S. Echt, P.R. Liebson, L.B. Mitchell, R.W. Peters, D. Obias-Manno, A.H. Baker, D. Arensberg, A. Baker et al., N. Engl. J. Med. 324 781-788 (1991).
4. E. Frey, G. Avril, E. Hartung, Cachiers d'Anesthesiologie 29 591-598 (1981).
5. L.N. Maslov and Yu.B. Lishmanov, Int. J. Cardiol. 40 89-94 (1993).
6. L.N. Maslov, A.V. Krylatov and Yu.B. Lishmanov, Bull. Exp. Biol. Med. (Russia) 122 25-27 (1996).
7. L.N. Maslov, Yu.B. Lishmanov, A.V. Krylatov and D.S. Ugdyzhekova, Exp. Clin. Pharmacol. (Russia) 59 20-22 (1996).
8. L.N. Maslov, A.V. Krylatov and Yu.B. Lishmanov, Exp. Clin. Pharmacol. (Russia) 5 24-26 (1997).
9. S.D. Mikhaylova, G.I. Strozhakov, N.A. Bebyakova and T.M. Semushkina, Bull. Exp. Biol. Med. (Russia) 123 509-512 (1997).
10. L.N. Maslov, Yu.B. Lishmanov and N.V. Naryzhnaya, Physiol. J. (Russia) 82 53-58 (1996).
11. C. Clark, M.I. Foreman, K. A. Kane, F. McDonald, J.R. Parratt, J. Pharmacol. Methods 3 357-368 (1980).
12. P.W. Schiller, T.M. Nguyen, N.N. Chung, G. Dionne, R. Martel, Prog. Clin. Biol. Res, 328 53-56 (1990).
13. N.V. Korobov, Pharmacol. and Toxicol. (Russia) 4 35-38 (1988).
14. Yu.B. Lishmanov, L.N. Maslov, D.S. Ugdyzhekova and G.N. Smagin, Life Sci. 61 PL33-38 (1997).
15. S.W. Tam, G.F. Steinfels, P.J. Gilligan, W.K. Schmidt and L. Cook, J. Pharmacol. Exp. Ther. 263 1167-1174 (1992).
16. M.R. Rosen, Antiarrhythmic Drugs. Mechanisms of Antiarrhythmic and Proarrhythmic Actions. G. Breithardt, M. Borggrefe, A.J. Camm, M. Shenasa (Eds), 393- 404, Springer-Verlag Berlin Heidelberg, New York (1995).
17. M. Novakova, C. Ela, J. Barg, Z. Vogel, Y. Hasin and Y. Eilam, Eur J. Pharmacol. 286 19-30 (1995).
18. C.C. Chien and G.W. Pasternak, Neurosci. Lett. 190 137-139 (1995).
19. J.A. Ruth and L.E. Eiden, Neuropeptides 4 101-108 (1984).
20. R.P. Xiao, S. Pepe, H.A. Spurgeon, M.C. Capogrossi and E.G. Lakatta, Am. J. Physiol. 272 H797-805 (1997).